Discordance of pathological thin melanoma thickness and T stage in SEER registry: impacts on clinical management and research directions
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The number of LN-negative Tis and T1 melanoma patients was 45595; the number of LN-positive T1 patients was 296. HR: hazard ratio; CI: confidence interval; LN, lymph node; # significant at 0.025 level after Borferroni correction of 4 to adjust for multiple comparison, reference group T1 0.01-0.10 mm group. The number of LN-negative Tis and T1 melanoma patients was 45595; the number of LN-positive T1 patients was 296. HR: hazard ratio; CI: confidence interval; LN, lymph node. # significant at 0.025 level after Borferroni correction of 4 to adjust for multiple comparison, reference group T1 0.01-0.10 mm group.
